REGN - Regeneron Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 534.99B
Enterprise Value 331.54B
Trailing P/E 15.18
Forward P/E 113.51
PEG Ratio (5 yr expected) 13.50
Price/Sales (ttm)5.06
Price/Book (mrq)3.72
Enterprise Value/Revenue 34.56
Enterprise Value/EBITDA 612.09

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 35.12%
Operating Margin (ttm)35.41%

Management Effectiveness

Return on Assets (ttm)13.76%
Return on Equity (ttm)30.32%

Income Statement

Revenue (ttm)6.91B
Revenue Per Share (ttm)63.86
Quarterly Revenue Growth (yoy)13.30%
Gross Profit (ttm)4.09B
EBITDA 2.61B
Net Income Avi to Common (ttm)2.43B
Diluted EPS (ttm)21.11
Quarterly Earnings Growth (yoy)-3.50%

Balance Sheet

Total Cash (mrq)3.23B
Total Cash Per Share (mrq)29.5
Total Debt (mrq)709.9M
Total Debt/Equity (mrq)7.52
Current Ratio (mrq)4.58
Book Value Per Share (mrq)86.22

Cash Flow Statement

Operating Cash Flow (ttm)2.47B
Levered Free Cash Flow (ttm)1.22B

Trading Information

Stock Price History

Beta (3Y Monthly) 1.05
52-Week Change 3-5.53%
S&P500 52-Week Change 36.43%
52 Week High 3442.00
52 Week Low 3295.27
50-Day Moving Average 3312.31
200-Day Moving Average 3374.40

Share Statistics

Avg Vol (3 month) 3823.3k
Avg Vol (10 day) 3709.39k
Shares Outstanding 5107.25M
Float 81.33M
% Held by Insiders 124.61%
% Held by Institutions 172.68%
Shares Short (May 31, 2019) 42.22M
Short Ratio (May 31, 2019) 42.46
Short % of Float (May 31, 2019) 42.78%
Short % of Shares Outstanding (May 31, 2019) 42.03%
Shares Short (prior month Apr 30, 2019) 42.65M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A